Ország: Hollandia
Nyelv: holland
Forrás: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
TIMOLOLMALEAAT SAMENSTELLING overeenkomend met ; TIMOLOL 0-WATER ; TRAVOPROST
Ratiopharm GmbH
S01ED51
TIMOLOLMALEAAT COMPOSITION corresponding to ; TIMOLOL 0-WATER ; TRAVOPROST
Oogdruppels, oplossing
BENZALKONIUMCHLORIDE ; BOORZUUR (E 284) ; DINATRIUMEDETAAT 2-WATER ; MACROGOLGLYCEROLHYDROXYSTEARAAT ; MANNITOL (D-) (E 421) ; NATRIUMHYDROXIDE (E 524) ; TROMETAMOL ; WATER VOOR INJECTIE,
Oculair gebruik
Timolol, Combinations
Hulpstoffen: BENZALKONIUMCHLORIDE; BOORZUUR (E 284); DINATRIUMEDETAAT 2-WATER; MACROGOLGLYCEROLHYDROXYSTEARAAT; MANNITOL (D-) (E 421); NATRIUMHYDROXIDE (E 524); TROMETAMOL; WATER VOOR INJECTIE;
2017-07-20
1 PACKAGE LEAFLET: INFORMATION FOR THE USER TRAVOPROST/TIMOLOL RATIOPHARM 40 MICROGRAM/ML + 5 MG/ML OOGDRUPPELS, OPLOSSING _ _ travoprost/timolol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Travoprost/Timolol is and what it is used for 2. What you need to know before you use Travoprost/Timolol 3. How to use Travoprost/Timolol 4. Possible side effects 5. How to store Travoprost/Timolol 6. Contents of the pack and other information 1. WHAT TRAVOPROST/TIMOLOL IS AND WHAT IT IS USED FOR Travoprost/Timolol eye drops solution is a combination of two active substances (travoprost and timolol). Travoprost is a prostaglandin analogue which works by increasing the outflow of liquid of the eye, which lowers its pressure. Timolol is a beta blocker which works by reducing the production of fluid within the eye. The two substances work together to reduce pressure within the eye. Travoprost/Timolol eye drops are used to treat high pressure in the eye in adults, including the elderly. This pressure can lead to an illness called glaucoma. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE TRAVOPROST/TIMOLOL DO NOT USE TRAVOPROST/TIMOLOL EYE DROPS SOLUTION: - if you are allergic to travoprost, timolol, or any of the other ingredients of this medicine (listed in section 6). - if you are allergic to any prostaglandins or beta-blockers. - if you have now or have had in the past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing Olvassa el a teljes dokumentumot
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Travoprost/Timolol ratiopharm 40 microgram/ml + 5 mg/ml oogdruppels, oplossing 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains 40 micrograms of travoprost and 5 mg of timolol (as timolol maleate). Excipient with known effect: Each ml of solution contains 0.15 mg of benzalkonium chloride and 5 mg of macrogolglycerol hydroxystearate (see section 4.4). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Eye drops, solution (eye drops). Clear, colourless solution. pH: 5.5-7.0 Osmolality: 252-308 mOsmol/Kg 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Travoprost/Timolol is indicated in adults for the decrease of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta- blockers or prostaglandin analogues (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Use in adults, including the older population The dose is one drop of Travoprost/Timolol in the conjunctival sac of the affected eye(s) once daily, in the morning or evening. It should be administered at the same time each day. If a dose is missed, treatment should be continued with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily. Special Populations Hepatic and renal impairment No studies have been conducted with Travoprost/Timolol or with timolol 5 mg/ml eye drops in patients with hepatic or renal impairment. Travoprost has been studied in patients with mild to severe hepatic impairment and in patients with mild to severe renal impairment (creatinine clearance as low as 14 ml/min). No dose adjustment was necessary in these patients. Rvg 119284 EoP EU SPC met NL info Patients with hepatic or renal impairment are unlikely to require dose adjustment with Travoprost/Timolol (see section 5.2). Paediatric population The safety and efficacy of Travoprost/Timolol in children and adolescents below the age of 18 year Olvassa el a teljes dokumentumot